BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 23026620)

  • 1. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
    Castroagudín JF; Molina-Pérez E; Ferreiro-Iglesias R; Abdulkader I; Otero-Antón E; Tomé S; Varo-Pérez E
    Transplant Proc; 2012; 44(6):1565-7. PubMed ID: 22841215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
    Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
    Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
    Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.
    Ataide EC; Boin IF; Almeida JR; Sevá-Pereira T; Stucchi RS; Cardoso AR; Caruy CA; Escanhoela CA
    Transplant Proc; 2011 May; 43(4):1362-4. PubMed ID: 21620130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
    Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
    de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
    Sharr WW; Chan SC; Lo CM
    Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
    Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.
    Koschny R; Schmidt J; Ganten TM
    Clin Transplant; 2009 Dec; 23 Suppl 21():49-60. PubMed ID: 19930317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.